Allergy Therapeutics (AGY)

Company name:Allergy Therapeutics Plc
EPIC:AGYTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00B02LCQ05
Market Segment:ASQ1Share Type:DE
WWW Address:Description:ORD 0.1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 11.25 images.advfn.com/imagesnew/2/gb/up 0.25 [2.27] 11.00 11.50 11.35 11.35 11.25 248,292
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 72.46 644.12 -0.00 0.55 - 20.45 - 16.00 - 7.35

Allergy Therapeutics Key Figures

(at previous day's close)
Market Cap.72.46m
Shares In Issue644.12m
Prev. Close11.00
PE Ratio20.45 
Dividend Yield-%
EPS - basic0.55p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.87p
Return On Equity (ROE)9.23%
Operating Margin5.82%
PEG Factor0.14 
EPS Growth Rate143.31%
Dividends PS Growth Rate-%
Net Debt3.50m
Gross Gearing45.17%
Quick Assets37.22m
Net Working Capital29.77m
Intangibles / Fixed Assets22.13%
Turnover PS11.44p
Pre-Tax Profit PS0.67p
Retained Profit PS0.54p
Cash PS4.26p
Net Cash PS1.64p
Net Tangible Asset Value PS *5.08p
Net Asset Value PS5.83p
Spread0.50 (4.35%) 

Allergy Therapeutics Balance Sheet

AGY:Liabilities+EQAGY:Assets

Share Price Performance

Sample Period HighLow
1 week12.0011.00
4 weeks12.009.90
12 weeks12.509.90
1 year16.007.35

Share Price Chart (5 years)

Allergy Therapeutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week11.35-0.10-0.8811.000.1711.19
4 weeks10.500.757.149.900.1810.89
12 weeks11.75-0.50-4.269.900.1610.99
26 weeks13.25-2.00-15.099.900.2111.41
1 year14.25-3.00-21.057.352.6111.06
3 years23.50-12.25-52.137.351.0513.49
5 years24.25-13.00-53.617.350.7214.63

Allergy Therapeutics Key Management Ratios

Allergy Therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio7.85 
PE Ratio20.45 
Tobin's Q Ratio 1.21 
Tobin's Q Ratio (excl. intangibles)1.32 
Dividend Yield-%
Market-to-Book Ratio1.93 
Price-to-Pre-Tax Profit PS16.88 
Price-to-Retained Profit PS20.90 
Price-to-Cash Flow PS12.94 
Price-to-Sales PS0.98 
Price-to-Net Tangible Asset Value PS2.21 
Price-to-Cash PS2.64 
Net Working Capital PS4.62 
Price Pct to Working Capital PS2.43%
Earnings Yield4.89%
Average PE559.60 
Years in average2 
PE to PE average3.66%

Allergy Therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio27.27%
Debt-to-Equity Ratio0.37 
Debt-to-Equity Ratio (excl. Intgbl)0.43 
Debt-to-Equity Market Value0.19 
Net Gearing5.11%
Net Gearing (excl. Intangibles)5.50%
Gross Gearing45.17%
Gross Gearing (excl. Intangibles)48.60%
Gearing Under 1 Year24.61%
Gearing Under 1 Year (excl. Intgbl)26.48%
Assets/Equity1.82 
Cash/Equity73.06 
(Liquidity Ratios)
Net Working Capital to Total Assets43.46%
Current Ratio2.77 
Quick Ratio (Acid Test)2.21 
Liquidity Ratio1.63 
Cash & Equiv/Current Assets58.85%
(Solvency Ratios)
Enterprise Value59.10m
CFO/Sales0.08 
CFO/Attributable Profit1.62 
CFO/Assets0.08 
CFO/Debt0.18 
Total Debt/Equity Market Value0.43 
Total Debt/Sales0.42 
Total Debt/Pre-Tax Profit7.21 
Total Debt30.94m
Total Debt/Net Current Assets1.04%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth94.03%
10 yr Compound Earnings Growth10.65%
Earn drops > 5% in 10yrs7 
Beta (60-Mnth)Beta (36-Mnth)
-0.00370.0216

Allergy Therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)8.31%
Return On Assets (ROA)5.80%
Net Profit Margin4.70%
Assets Turnover1.23 
Return On Equity (ROE)9.23%
Return On Investment (ROI)7.88%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio11.44%
Net Income Of Revenues4.70%
(Asset Utilisation Multiples)
Shareholders Equity Turnover2.43 
Fixed Assets Turnover3.51 
Current Assets Turnover1.90 
Net Working Capital Turnover 
Inventory Turnover8.09 
(Other Operating Ratios)
Total Assets-to-Sales0.81 
Debtors-to-Sales11.10%
Debt Collection Period40.51Days

Allergy Therapeutics Dividends

Sorry No Data Available

Allergy Therapeutics Fundamentals

 30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
turnover48.51100.00%64.14100.00%68.35100.00%73.72100.00%m
pre tax profit-12.06-24.87%-1.97-3.07%-6.90-10.09%4.295.82%m
attributable profit-13.07-26.95%-2.48-3.87%-7.53-11.02%3.474.70%m
retained profit-13.07-26.95%-2.48-3.87%-7.53-11.02%3.474.70%m
eps - basic (p)-2.29 -0.42 -1.27 0.55 
eps - diluted (p)-2.29 -0.42 -1.27 0.52 
dividends per share- - - - 

Allergy Therapeutics Balance Sheet

 30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
AGY:Liabilities+EQAGY:AssetsAGY:Liabilities+EQAGY:AssetsAGY:Liabilities+EQAGY:AssetsAGY:Liabilities+EQAGY:Assets
 30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
ASSETS
fixed assets fixed assets9.6717.06%9.6716.92%10.1019.79%11.4816.76%m
intangibles intangibles5.369.45%5.469.55%4.959.70%4.847.07%m
fixed investments fixed investments4.057.14%4.598.03%5.049.89%5.558.10%m
current assets - other current assets - other--%--%--%--%m
stocks stocks7.6913.57%7.4813.09%8.8117.27%9.4113.74%m
debtors debtors6.5111.49%7.8513.73%6.5912.91%9.7814.27%m
cash & securities cash & securities23.4141.30%22.1238.69%15.5330.45%27.4440.06%m
TOTAL56.68100%57.18100%51.02100%68.50100%m
LIABILITIES
creditors - short creditors - short12.5222.09%14.0224.52%14.6328.68%16.8624.61%m
creditors - long creditors - long13.8424.41%13.2023.08%13.3526.17%14.0820.56%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL26.3646.50%27.2247.60%27.9854.85%30.9445.17%m
EQUITY
ord cap, reserves ord cap, reserves30.3253.50%29.9752.40%23.0345.15%37.5654.83%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL30.3253.50%29.9752.40%23.0345.15%37.5654.83%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Allergy Therapeutics Cash Flow Statement

30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
Operating CF-11.840.18-3.805.60m
Pre-Financing CF-13.33-1.77-6.312.25m
Retained CF-0.79-1.95-6.6011.79m

Allergy Therapeutics Brokers

NameActivityTypeMnemonicCode
Nomura Code Securities LimitedMarket Maker(MMF)Broker/DealerCODECODCGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Piper Jaffray LtdMarket Maker(MMF)Broker/DealerPIPRPIPRGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
AGY
Allergy Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200119 17:25:41